YAP/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis

Ruize Gao, Ravi K.R. Kalathur, Mairene Coto-Llerena, Caner Ercan, David Buechel, Song Shuang, Salvatore Piscuoglio, Michael T. Dill, Fernando D. Camargo, Gerhard Christofori*, Fengyuan Tang*

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

329 Citations (Scopus)

Fingerprint

Dive into the research topics of 'YAP/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science